MONOCLONAL ANTIBODY INDEX. Cancer -- 2012 update.

MOAB DATA TABLE (Ordered by MOAB NAME).
OUR ID	MOAB NAME	RELATED MOAB	SPECIES	IG TYPE	MOAB/CELL LINE CHARACTERISTICS	TARGET CELL/TISSUE	TARGET CANCER(*)	AG/EPITOPE NAME	AG Mw/kDa (ip)	AG/EPITOPE CHARACTERISTICS	STUDY PHASE(**)	PATENT ASSIGNEE/PRODUCER/DEVELOPER/DISTRIBUTOR (other names of the moab, antigen or derivatives)
1351	Lym-1	IL-2 fusion proteins, chimeric (IgG1) and scFv variants, radiolabeled derivatives	m	G2a	Ka= 4.02x10(8) M(-1) / bsc= 1.1x10(6)	B lymphocytes	lymphoma (NHL), leukemia	-	31-35	light chain of polymorphic HLA-DR10 (class II) protein	II-III	Southern California Univ., US / Northwestern Univ., US / Techniclone, US (Oncolym) / Schering, Germany / Peregrine Pharm., US / Berlex Labs., US